Immuron Ltd current report, Q4 FY2019

Business Context and Reporting Period

This Form 6-K filing by Immuron Limited, a foreign private issuer, covers the month of November 2019. The report serves to disseminate two announcements published to the Australian Securities Exchange on November 6, 2019: the "2019 AGM Presentation" and the "Results of Meeting."

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a cover sheet referencing attached exhibits containing the actual presentation and meeting results, but the financial data itself is not embedded in the provided text.

Material Changes

No material changes versus prior periods are detailed in the filing text. The content is limited to the notification of the Annual General Meeting (AGM) materials.

Guidance, Outlook, and Risks

The filing does not contain specific management commentary, guidance, outlook, or risk factors within the body text. These details are presumed to be contained within the attached exhibits (Exhibit 99.1 and 99.2) which are not included in the source text provided.

Investor Verification Checklist

  • Verify the specific financial results and operational updates contained in the attached "2019 AGM Presentation" (Exhibit 99.1).
  • Review the "Results of Meeting" (Exhibit 99.2) for any shareholder resolutions or governance changes.
  • Confirm the company's cash position and burn rate, as these are not stated in the filing summary.
  • Check for any new clinical trial milestones or regulatory updates discussed during the AGM.